Treatment-related microangiopathic glomerulopathy and severe chronic kidney disease (CKD) in recurrent epithelial ovarian cancer (rEOC): A possible relationship with pegylated liposomal doxorubicin (PLD)

Authors :: Ora Rosengarten
Alberto Gabizon
H. Jones
A. Hung
J. Kopolovic
Igor Puzanov
Linda Shavit
F. Muggia
R. A. Baumgartner
Maryann Kwa
I. Barash
J. Michael
Source :: Journal of Clinical Oncology. 29:e15551-e15551
Publication Year :: 2011
Publisher :: American Society of Clinical Oncology (ASCO), 2011.
Abstract: e15551 Background: Treatment-related CKD and hypertension (HTN) are emerging as problems in patients receiving multiple treatments for recurrent epithelial ovarian cancer (rEOC). Methods: 8 patient...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
female genital diseases and pregnancy complications
Pegylated Liposomal Doxorubicin
Glomerulopathy
Internal medicine
Immunology
Multiple treatments
Medicine
In patient
Epithelial ovarian cancer
cardiovascular diseases
business
Kidney disease

Full Text Access

Tools